Commonwealth Equity Services
BPMC

Commonwealth Equity Services’s Blueprint Medicines BPMC Stock Holding History

Commonwealth Equity Services’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,698
Closed -$218K – 4251
2025
Q2 		$218K Buy
+1,698
New +$176K ﹤0.01% 3851

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Commonwealth Equity Services's BPMC Position: Q3 2025 in Review

Commonwealth Equity Services sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 1,698 shares — an estimated $218K sold.

Commonwealth Equity Services first reported a position in BPMC in Q2 2025 and held it in 1 quarter. The position peaked at $218K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Commonwealth Equity Services reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 1,698 Blueprint Medicines shares in Q3 2025, an estimated $218K.
  • Commonwealth Equity Services first reported a position in Blueprint Medicines in Q2 2025 and held it in 1 quarter.
  • Commonwealth Equity Services's Blueprint Medicines position peaked at $218K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Commonwealth Equity Services's 13F filing for Q3 2025, filed 22 Oct 2025.